Key result
Video-assisted minimally invasive mitral valve replacement significantly reduced hospital stay (6.13 vs 13.27 days, P<0.001) and ICU stay compared to conventional sternotomy.
Why the study?
Although minimally invasive mitral valve surgery offers cosmetic advantages over conventional surgery, whether it is superior in other clinical aspects remains debatable.
Does video-assisted minimally invasive mitral valve replacement improve intraoperative and postoperative outcomes compared to conventional sternotomy in patients with rheumatic heart disease?
Cohort (n=60)
No
Does video-assisted minimally invasive mitral valve replacement improve intraoperative and postoperative outcomes compared to conventional sternotomy in patients with rheumatic heart disease?
Absolute Event Rate: 6.13% vs 13.27%
p-value: p=<0.001
Video-assisted minimally invasive mitral valve replacement is a safe alternative to conventional sternotomy in rheumatic patients, offering reduced bleeding, shorter ventilation time, and faster hospital discharge despite longer procedural times.
May shorten hospital stay in rheumatic MVR; leaves open confirmation of safety and net benefit by RCTs.
Background: Minimally invasive mitral valve surgery became an attractive option because of its cosmetic advantages over the conventional approach. The superiority of the minimally invasive approach regarding other aspects is still debatable. The aim of our study was to determine the potential benefits of minimally invasive mitral valve replacement with intraoperative video assistance over conventional surgery. Methods: This is a single-center prospective cohort study that included 60 patients with rheumatic heart disease who underwent mitral valve replacement. Patients were divided into two groups: group (A) included patients who had conventional sternotomy (n= 30), and group (B) included patients who had video-assisted minimally invasive mitral valve replacement (n= 30). Intraoperative and postoperative outcomes were compared between both groups. Results: Mortality occurred in one patient in the group (A). Cardiopulmonary bypass time was 118.93 ± 29.84 minutes vs. 64.73 ± 19.16 minutes in group B and A respectively (p< 0.001), and ischemic time was 102.27 ± 30.03 minutes vs. 53.67± 18.46 minutes in group B and A respectively (P < 0.001). Ventilation time was 2.77± 2.27 vs. 6.28 ± 4.48 hours in group B and A respectively (p< 0.001) and blood transfusion was 0.50 ± 0.63 vs. 2.83 ± 1.34 units in group B and A respectively (p< 0.001). ICU stay was 1.73 ± 0.64 days in the group (B) vs. 4.47 ± 0.94 days in group A (p< 0.001). Postoperative bleeding was 353.33 ± 146.77 ml in the group (B) vs. 841.67 ± 302.03 ml in group A (p <0.001). No conversion to full sternotomy was reported in group B. In group (B), two cases (6.6%) required re-exploration for bleeding vs. four cases (13.2%) in group (A) (p=0.67). The hospital stay was 6.13 ± 1.59 days in the group (B) vs. 13.27 ± 7.62 days in group A (p< 0.001). Four cases (13.3%) developed mediastinitis in group A and in the group (B), there was one case of acute right lower limb embolic ischemia. Conclusion: Video-assisted minimally invasive mitral operations could be a safe alternative to conventional sternotomy with the potential of lesser morbidity and earlier hospital discharge.
No takes yet. Share an insight, caveat, or question.
Badawy et al. (2020) conducted a cohort in Rheumatic heart disease (n=60). Video-assisted minimally invasive mitral valve replacement vs. Conventional sternotomy was evaluated on Hospital stay (days) (p=<0.001). Video-assisted minimally invasive mitral valve replacement significantly reduced hospital stay (6.13 vs 13.27 days, P<0.001) and ICU stay compared to conventional sternotomy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: